Skip to main content
. 2020 Sep 9;10:1786. doi: 10.3389/fonc.2020.01786

TABLE 1.

The application of oncolytic virus for cancer diagnosis.

Imaging techniques Cancer Viruses Genes Results
Bioluminescence imaging (27) Breast cancer Herpes simplex virus, Herpes simplex virus-1, Herpes simplex virus-Luc Luciferase Viral replication cycles can be monitored by bioluminescence imaging
Fluorescence imaging (28) Breast cancer Vaccinia virus, Lister strain GLV 1h153 Green fluorescent protein All positive surgical margins can be observed through FI by the infection of GLV-1h153
SPECT/CT (29) Prostate cancer Adenovirus serotype, adenovirus serotype 5, adenovirus serotype 5-yCD/mutTKSR3 9rep-hNIS Human Na+/I- symporter gene Tumor imaging was detected in seven of nine (78%) patients
PET (30) Gastric cancer Vaccinia virus, Lister strain, GLV-1h153 Human Na+/I- symporter gene Tumor imaging can be visualized through 99mTc pertechnetate SPECT and 124I PET by the infection of hNIS expressing GLV-1h153
MRI (31) Prostate tumor Vaccinia virus, Lister strain, GLV-1h68, GLV-1h312, GLV-1h460, GLV-1h462 Tyrosinase, Tyrosinase p1, Tyrosinase p2, Melanin The tumor signal enhancement of MRI can be detected after infection of GLV-1h462. The expression of melanin can be controlled by the doxycycline inducible promoter-system and thereby decrease inhibition of viral replication due to melanin overproduction

GLV, green fluorescent protein-expressing vaccinia virus.